Showing results (21-30 of 258) with videos related to
Sort By:
Pageof 26
Psychopharmacology|January 1, 1983
Clinical response and plasma haloperidol levels in schizophreniaM L Mavroidis, D R Kanter, J Hirschowitz, et al.Psychiatry Research|March 1, 1984
Platelet monoamine oxidase activity in the psychoses: relationship to symptoms and lithium responseR J Hitzemann, F Sautter, B Hitzemann, et al.Psychological Medicine|November 1, 1988
Drug response patterns as a basis of nosology for the mood-incongruent psychoses (the schizophrenias)D L Garver, K Kelly, K A Fried, et al.Psychopharmacology|January 1, 1984
Dopamine and non-dopamine psychosesD L Garver, F Zemlan, J Hirschowitz, et al.The American Journal of Psychiatry|August 1, 1981
Physostigmine and lithium response in the schizophreniasP Edelstein, J R Schultz, J Hirschowitz, et al.Journal of Clinical Psychopharmacology|June 1, 1984
Haloperidol plasma and red blood cell levels and clinical antipsychotic responseD L Garver, J Hirschowitz, G A Glicksteen, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Velnacrine for the treatment of Alzheimer's disease: a double-blind, placebo-controlled trial. The Mentane Study GroupF P ZemlanEuropean Archives of Psychiatry and Clinical Neuroscience|January 1, 1990
Anticholinergic serum levels and cognitive performanceO J Thienhaus, A Allen, J A Bennett, et al.Brain Research|June 21, 1988
Nucleus cuneiformis and pain modulation: anatomy and behavioral pharmacologyF P Zemlan, M M BehbehaniNeuropeptides|March 1, 1990
Bulbospinal and intraspinal thyrotropin releasing hormone systems: modulation of spinal cord pain transmissionM M Behbehani, F P ZemlanPageof 26